万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://home.liebertpub.com/publications/journal-of-adolescent-and-young-adult-oncology/387
3、投稿网址：https://mc.manuscriptcentral.com/JAYAO
4、官网邮箱：kcloudhansen@liebertpub.com（总编）
5、期刊刊期：双月刊，逢双月出版。
2021年8月2日星期一
投稿须知【官网信息】
Information For Authors
Journal of Adolescent and Young Adult Oncology (JAYAO) welcomes quantitative and qualitative clinical, basic science, and psychosocial manuscript submissions on all topics related to adolescent and young adult-aged cancer patients and survivors, including AYA-aged survivors of pediatric cancer.
JAYAO generally uses the National Cancer Institute's designated AYA age range of 15-39; however, it is acceptable for manuscripts submitted from institutions or countries typically using a younger lower age limit to use the lower age limit as appropriate. For a discussion about the age range included in adolescent and young adult oncology, please see the Controversies piece in JAYAO's inaugural issue (J Adolesc Young Adult Oncol. 2011;1(1):3-10).
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
Please read all Instructions for Authors carefully before submitting your paper. All papers are subject to peer review and must be uploaded to the following peer-review website: https://mc.manuscriptcentral.com/JAYAO
Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in Journal of Adolescent and Young Adult Oncology. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.
Article Types
Note: All articles are peer-reviewed unless otherwise noted. Note the listed limits for text, figures/tables, and references below, but please be concise across all manuscript components. Those interested in an exception to a posted limit must contact the Editors prior to submission.
Original Articles present original quantitative or qualitative basic science, clinical, or psychosocial research
Abstract: Standard abstract 250 word limit. See standard abstract guidelines under Manuscript Components.
Text: 3,000 word limit.
Figures and Tables: Maximum of 8 total figures and/or tables.
References: Maximum of 100 references.
Review articles are systematic and critical reviews of the current literature on a topic
Abstract: Standard abstract 250 word limit, but structured headings not required.
Text: 4,500 word limit. Details on the study selection and inclusion process and on the participants in each selected study should be included.
Figures and Tables: Maximum of 10 total figures and/or tables.
References: Maximum of 250 references.
Case Study articles are unusual, illustrative, or instructive AYAO-relevant clinical cases
Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
Text: 1,750 word limit. Include a concise literature review, brief overview of the case, and a brief summarizing conclusion. Be sure to discuss the relevance or importance of the case to AYAO.
Figures and Tables: Maximum of 3 total figures and/or tables.
References: Maximum of 25 references.
Brief Reports articles are short pieces about pilot studies, preliminary findings, very small sample sizes, or other research findings that are not suitable for a full Original Article
Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
Text: 2,000 word limit. Include a concise literature review and a brief overview of the study, sufficient details on the study's methods and analysis, and a brief summarizing conclusion.
Figures and Tables: Maximum of 3 total figures and/or tables.
References: Maximum of 25 references.
Perspective articles are short pieces in which authors share or argue a viewpoint grounded in the literature but not linked to a specific article
Abstract: The final print version of accepted Perspective articles will not have an abstract. However, please include a maximum 100 word abstract with the submission to facilitate the review process.
Text: 1,500 word limit. The first paragraph should be a brief overview as there is no abstract. The perspective and points should be grounded in the literature. Include a brief summarizing conclusion.
Figures and Tables: Maximum of 3 total figures and/or tables.
References: Maximum of 25 references.
Letters to the Editor comment on recently published JAYAO articles
Special Notes: Letters to the Editor should be submitted within 6 weeks of the article's publication in print form. Include a short title related to but distinct from the recently published article. Provide the standard Title page, but no Running Head or Keywords. The Editors may choose to invite the authors to submit a response to the Letter. Not peer reviewed.
Abstract: The final print version of accepted Letters to the Editor will not have an abstract. However, please include a maximum 100 word abstract with the submission to facilitate processing.
Text: 500 word limit.
Figures and Tables: Maximum of 1 total figure and/or table.
References: No more than 5 references, one of which must be the JAYAO article being discussed.
Article Types that are Invite-Only or Require Pre-Submission Inquiry
Roundtable articles are transcribed discussions on a topic by leading members of the AYAO community
Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.
Controversies articles include short responses by invited participants to hot topics in AYAO
Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.
Clinical Trial Spotlight articles are brief summaries of clinical trials of importance or relevance to AYAO and still open to accrual
Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.
Editorial pieces provide commentary and analysis of an article in the issue of JAYAO in which it appears
Invitation only. Not peer reviewed.
Book Reviews are 500-750 word pieces critically reviewing a book of AYAO-relevance
Invitation only, although those with a suggestion of a book to be reviewed are welcome to contact the Editors. Not peer reviewed.
Special Articles may include guidelines, meeting summaries, consensus statements, or other non-standard communications
Please contact the Editors prior to submission. May be subject to peer review.
Online Manuscript Submission
Manuscripts must be uploaded to Manuscript Central in a word processing format, preferably in Microsoft Word. Do not submit the manuscript or any of its components in PDF format. All authors on a submitted manuscript must have a Manuscript Central account.
Keywords and Abstract
Please note the keywords and abstract entered online in Manuscript Central are only to aid with the review process and are separate from the keywords and abstract on the title page for inclusion in the article.
Suggested Reviewers
Authors are encouraged to suggest the names and emails of appropriate reviewers, at least one of whom is not a member of JAYAO’s Editorial Board, during Manuscript Central submission, though final selection of reviewers is at the discretion of the Editors.
Cover Letter
Please include a cover letter from the corresponding author. The cover letter should include the following:
Running head character count (including spaces)
Abstract word count
Main text word count
Number of tables
Number of figures
Number of appendices (if applicable)
If the authors have published or submitted any related papers from the same study
If pre-submission permission was obtained to exceed the article type’s word limit
Authors are encouraged to detail the significance and uniqueness of the work
PUBLICATION ETHICS AND MALPRACTICE STATEMENT
Study Design and Ethics
Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.
Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.
Definitions of Scientific Misconduct
Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).
Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:
Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.
Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
Material failure to comply with legislative and regulatory requirements affecting research:
Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.
Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.
Responding to Allegations of Possible Misconduct
The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.
When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.
Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.
If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.
……
更多详情：
https://home.liebertpub.com/publications/journal-of-adolescent-and-young-adult-oncology/387/for-authors
